tetradecanoylphorbol acetate has been researched along with tesmilifene in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beecroft, WA; Brandes, LJ; Hogg, GR | 1 |
| Salmon, DM | 1 |
2 other study(ies) available for tetradecanoylphorbol acetate and tesmilifene
| Article | Year |
|---|---|
Stimulation of in vivo tumor growth and phorbol ester-induced inflammation by N,N-diethyl-2-[4-(phenylmethyl)phenoxy] ethanamine HCl, a potent ligand for intracellular histamine receptors.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Cell Division; Drug Synergism; Epithelium; Female; Histamine Antagonists; Hyperplasia; Inflammation; Leukemia L5178; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred DBA; Mitotic Index; Phenyl Ethers; Rats; Rats, Inbred Strains; Receptors, Histamine; Skin; Tetradecanoylphorbol Acetate | 1991 |
Inhibition of platelet responses by N,N-diethyl-2[4-(phenoxymethyl)phenoxy]ethanamine, HCl (DPPE) occurs through multiple mechanisms.
Topics: Blood Platelets; Calcium; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Ionomycin; Kinetics; Phenyl Ethers; Platelet Aggregation Inhibitors; Second Messenger Systems; Serotonin; Tetradecanoylphorbol Acetate; Thrombin | 1993 |